Gonzalo Hernandez
Getxo, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Vitamin D in the prevention of left ventricular remodelling after an acute myocardial infarction: a randomized clinical trial.
Journal: Scientific reports
Published: November 07, 2025
Age- and sex-specific lipoprotein profiles in general and cardiometabolic population cohorts.
Journal: EBioMedicine
Published: May 15, 2025
The new bilastine eye drop formulation protects against conjunctival dehydration and promotes corneal wound healing in a comparative in vitro study.
Journal: Scientific reports
Published: April 06, 2024
The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study.
Journal: Scientific reports
Published: January 10, 2024
Bilastine 0.6% Preservative-Free Eye Drops as an Effective Once-Daily Treatment for the Signs and Symptoms of Allergic Conjunctivitis: A Pooled Analysis of 2 Randomized Clinical Trials.
Journal: Journal of investigational allergology & clinical immunology
Published: September 21, 2023
Bilastine 0.6% Preservative-free Eye Drops: A Once-daily Treatment for Allergic Conjunctivitis.
Journal: Journal of investigational allergology & clinical immunology
Published: February 22, 2023
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: November 18, 2022
Ocular Biodistribution of Once-Daily 0.6% Bilastine Eye Drops Reveals Highest Levels in Conjunctiva Up to 24 h Postadministration.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: October 21, 2022
Efficacy of Once-Daily Ophthalmic Bilastine for the Treatment of Allergic Conjunctivitis: A Dose-Finding Study.
Journal: Journal of investigational allergology & clinical immunology
Published: March 02, 2022
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation.
Journal: Advances in therapy
Published: March 31, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026